We are live on ! Find out more
GDRX icon

GoodRx Holdings

159 hedge funds and large institutions have $853M invested in GoodRx Holdings in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $2.27M

5% more capital inflows, than outflows

Capital inflows: $50.1M | Capital outflows: $47.7M

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

0.28% more ownership

Funds ownership: 147.09% → 147.37% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 160 → 159 (-1)

11% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 55

Holders
159
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
2.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
49
Reduced
55
Closed
21
Calls
$3.14​M
Puts
$2.27​M
Net Calls
+$876​K
Net Calls Change
-⁠$677​K

GDRX Hedge Fund Activity: Q1 2023 in Review

159 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q1 2023, worth a combined $853M — up 35% from $633M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new GDRX positions and 21 closed out — a net gain of 1 holder — while 49 added to existing stakes and 55 trimmed.

The largest buyer was OrbiMed, adding an estimated $7.32M. The largest seller was Millennium Management, cutting an estimated $14.1M.

  • 159 institutional investors held GoodRx Holdings (GDRX) as of Q1 2023, down from 160 in Q4 2022.
  • Funds reported $853M of GoodRx Holdings stock for Q1 2023, up 35% quarter-over-quarter.
  • 22 funds opened new GoodRx Holdings positions in Q1 2023 and 21 closed out, a net change of +1 holder.
  • The largest GoodRx Holdings buyer in Q1 2023 was OrbiMed, an estimated $7.32M added.
  • The largest GoodRx Holdings seller in Q1 2023 was Millennium Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q1 2023.